Dimensional Fund Advisors
LYEL icon

Dimensional Fund Advisors’s Lyell Immunopharma LYEL Stock Holding History

Dimensional Fund Advisors’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$959K Buy
+47,888
New +$1.12M ﹤0.01% 2850
2025
Q2 		– Sell
-673
Closed -$7.24K – 3309
2025
Q1 		$7.24K Hold
673
– – ﹤0.01% 3318
2024
Q4 		$8.62K Sell
673
-157
-19% -$3.11K ﹤0.01% 3337
2024
Q3 		$22.9K Sell
830
-1,175
-59% -$34.5K ﹤0.01% 3329
2024
Q2 		$58.1K Buy
2,005
+1,332
+198% +$63.4K ﹤0.01% 3299
2024
Q1 		$30K Hold
673
– – ﹤0.01% 3353
2023
Q4 		$26.1K Hold
673
– – ﹤0.01% 3381
2023
Q3 		$19.8K Hold
673
– – ﹤0.01% 3443
2023
Q2 		$42.8K Sell
673
-1,464
-69% -$81K ﹤0.01% 3417
2023
Q1 		$101K Sell
2,137
-4,593
-68% -$246K ﹤0.01% 3297
2022
Q4 		$467 Buy
6,730
+766
+13% +$76.1K ﹤0.01% 3046
2022
Q3 		$874K Buy
+5,964
New +$808K ﹤0.01% 2919

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
GP
GSK plc London $599M AUM
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors's LYEL Position: Q1 2026 in Review

Dimensional Fund Advisors opened a new position in Lyell Immunopharma (LYEL) in Q1 2026: 47,888 shares worth $959K. The stake represents ﹤0.01% of the portfolio and ranks #2850 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in LYEL as recently as Q1 2025.

Dimensional Fund Advisors first reported a position in LYEL in Q3 2022 and has held it in 12 quarters since. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.

  • Dimensional Fund Advisors held 47,888 shares of Lyell Immunopharma worth $959K as of Q1 2026.
  • Lyell Immunopharma was a new Dimensional Fund Advisors position in Q1 2026.
  • Lyell Immunopharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2850 holding.
  • Dimensional Fund Advisors first reported a position in Lyell Immunopharma in Q3 2022 and has held it in 12 quarters since.
  • 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.